Erratum: Cyclophilin d modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol(Int J Oncol (2013) 42 (1654-1663) DOI: 10.3892/ijo.2013.1863);Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1654-1663

  Tian, Wei ^a   Xu, Dong ^a   Han, Weidong ^b   He, Haifei ^a   Cai, Hongke ^a   Chen, Hailong ^a   Zhou, Meiqi ^a   Chen, Jiani ^a   Deng, Yong Chuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cyclophilin D; Honokiol; Programmed necrosis; Receptor interacting protein kinases 1; Receptor interacting protein kinases 3

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHILIN D; CYCLOSPORIN A; DNA; HONOKIOL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84875990110     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/IJO.2021.5212     Document Type: Erratum

References (44)

1. Galluzzi L, Vitale I, Abrams JM, et al: Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19: 107-120, 2012.
2. Vanlangenakker N, Vanden Berghe T and Vandenabeele P: Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19: 75-86, 2012.
3. Han J, Zhong CQ and Zhang DW: Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12: 1143-1149, 2011.
4. Tian W, Xu D and Deng YC: Honokiol, a multifunctional tumor cell death inducer. Pharmazie 67: 811-816, 2012.
5. Battle TE, Arbiser J and Frank DA: The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697, 2005. (Pubitemid 40981267)
6. Park EJ, Min HY, Chung HJ, et al: Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 277: 133-140, 2009.
7. Raja SM, Chen S, Yue P, et al: The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Mol Cancer Ther 7: 2212-2223, 2008.
8. Shigemura K, Arbiser JL, Sun SY, et al: Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109: 1279-1289, 2007. (Pubitemid 46466554)
9. Chen YJ, Wu CL, Liu JF, et al: Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Lett 291: 20-30, 2010.
10. Mannal PW, Schneider J, Tangada A, McDonald D and McFadden DW: Honokiol produces anti-neoplastic effects on melanoma cells in vitro. J Surg Oncol 104: 260-264, 2011.
11. Li L, Han W, Gu Y, et al: Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67: 4894-4903, 2007. (Pubitemid 46910198)
12. Xu D, Lu Q and Hu X: Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280, 2006. (Pubitemid 44485849)
13. Orrenius S, Nicotera P and Zhivotovsky B: Cell death mechanisms and their implications in toxicology. Toxicol Sci 119: 3-19, 2011.
14. Nakagawa T, Shimizu S, Watanabe T, et al: Cyclophilin D dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652-658, 2005. (Pubitemid 40488558)
15. Schubert A and Grimm S: Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res 64: 85-93, 2004. (Pubitemid 38114085)
16. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J and Gunter TE: Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 284: 9692-9699, 2009.
17. Rasola A and Bernardi P: The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815-833, 2007. (Pubitemid 46653292)
18. Zhang DW, Zheng M, Zhao J, et al: Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes. Cell Res 21: 368-371, 2011.
19. Kreuzaler P and Watson CJ: Killing a cancer: what are the alternatives? Nat Rev Cancer 12: 411-424, 2012.
20. Zhang DW, Shao J, Lin J, et al: RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336, 2009.
21. He S, Wang L, Miao L, et al: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111, 2009.
22. Li J, McQuade T, Siemer AB, et al: The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150: 339-350, 2012.
23. Moquin D and Chan FK: The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci 35: 434-441, 2010.
24. Declercq W, Vanden Berghe T and Vandenabeele P: RIP kinases at the crossroads of cell death and survival. Cell 138: 229-232, 2009.
25. Kurokawa M and Kornbluth S: Caspases and kinases in a death grip. Cell 138: 838-854, 2009.
26. Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18: 1414-1424, 2011.
27. Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
28. Song MS, Salmena L and Pandolfi PP: The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296, 2012.
29. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
30. Martelli AM, Evangelisti C, Chappell W, et al: Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia 25: 1064-1079, 2011.
31. Wolf I, O'Kelly J, Wakimoto N, et al: Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 30: 1529-1537, 2007.
32. Liu H, Zang C, Emde A, et al: Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591: 43-51, 2008.
33. Mocarski ES, Upton JW and Kaiser WJ: Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 12: 79-88, 2012.
34. Sun L, Wang H, Wang Z, et al: Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-227, 2012.
35. Motani K, Kushiyama H, Imamura R, Kinoshita T, Nishiuchi T and Suda T: Caspase-1 protein induces apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)-mediated necrosis independently of its catalytic activity. J Biol Chem 286: 33963-33972, 2011.
36. Cho YS, Challa S, Moquin D, et al: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123, 2009.
37. Upton JW, Kaiser WJ and Mocarski ES: Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313, 2010.
38. Rebsamen M, Heinz LX, Meylan E, et al: DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 10: 916-922, 2009.
39. Ono K, Wang X, Kim SO, Armstrong LC, Bornstein P and Han J: Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Protein Cell 1: 161-173, 2010.
40. Jeong JJ, Lee JH, Chang KC and Kim HJ: Honokiol exerts an anticancer effect in T98G human glioblastoma cells through the induction of apoptosis and the regulation of adhesion molecules. Int J Oncol 41: 1358-1364, 2012.
41. Arora S, Bhardwaj A, Srivastava SK, et al: Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 6: e21573, 2011.
42. Han LL, Xie LP, Li LH, Zhang XW, Zhang RQ and Wang HZ: Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells. Environ Toxicol Pharmacol 28: 97-103, 2009.
43. Deng J, Qian Y, Geng L, et al: Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2). Liver Int 28: 1458-1464, 2008.
44. Hahm ER, Arlotti JA, Marynowski SW and Singh SV: Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14: 1248-1257, 2008. (Pubitemid 351302574)